CareRx (29C1) Stock Overview
Provides pharmacy services to senior homes and other congregate care settings in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
29C1 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CareRx Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.38 |
| 52 Week High | CA$2.46 |
| 52 Week Low | CA$1.43 |
| Beta | 0.78 |
| 1 Month Change | 1.71% |
| 3 Month Change | 12.26% |
| 1 Year Change | 60.81% |
| 3 Year Change | 15.53% |
| 5 Year Change | -5.56% |
| Change since IPO | -69.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 29C1 | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 2.6% | 0.06% | 0.5% |
| 1Y | 60.8% | 6.0% | 14.8% |
Return vs Industry: 29C1 exceeded the German Consumer Retailing industry which returned 5.2% over the past year.
Return vs Market: 29C1 exceeded the German Market which returned 14.6% over the past year.
Price Volatility
| 29C1 volatility | |
|---|---|
| 29C1 Average Weekly Movement | 5.3% |
| Consumer Retailing Industry Average Movement | 5.9% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 12.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 29C1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 29C1's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,466 | Puneet Khanna | www.carerx.ca |
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company offers medication management, technology, and program services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes.
CareRx Corporation Fundamentals Summary
| 29C1 fundamental statistics | |
|---|---|
| Market cap | €152.20m |
| Earnings (TTM) | €57.66k |
| Revenue (TTM) | €227.14m |
Is 29C1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 29C1 income statement (TTM) | |
|---|---|
| Revenue | CA$366.34m |
| Cost of Revenue | CA$257.14m |
| Gross Profit | CA$109.20m |
| Other Expenses | CA$109.11m |
| Earnings | CA$93.00k |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0015 |
| Gross Margin | 29.81% |
| Net Profit Margin | 0.025% |
| Debt/Equity Ratio | 50.8% |
How did 29C1 perform over the long term?
See historical performance and comparisonDividends
Does 29C1 pay a reliable dividends?
See 29C1 dividend history and benchmarks| CareRx dividend dates | |
|---|---|
| Ex Dividend Date | Dec 23 2025 |
| Dividend Pay Date | Jan 21 2026 |
| Days until Ex dividend | 25 days |
| Days until Dividend pay date | 4 days |
Does 29C1 pay a reliable dividends?
See 29C1 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/15 17:48 |
| End of Day Share Price | 2026/01/15 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CareRx Corporation is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Doug Cooper | Beacon Securities Limited |
| Prasath Pandurangan | Bloom Burton & Co. |
| David Martin | Bloom Burton & Co. |